BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8540612)

  • 1. Divergent differentiation in pleomorphic xanthoastrocytoma. Evidence for a neuronal element and possible relationship to ganglion cell tumors.
    Powell SZ; Yachnis AT; Rorke LB; Rojiani AM; Eskin TA
    Am J Surg Pathol; 1996 Jan; 20(1):80-5. PubMed ID: 8540612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Giant cell glioblastoma and pleomorphic xanthoastrocytoma show different immunohistochemical profiles for neuronal antigens and p53 but share reactivity for class III beta-tubulin.
    Martinez-Diaz H; Kleinschmidt-DeMasters BK; Powell SZ; Yachnis AT
    Arch Pathol Lab Med; 2003 Sep; 127(9):1187-91. PubMed ID: 12946225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleomorphic xanthoastrocytoma as a component of a temporal lobe cystic ganglioglioma: a case report.
    Sugita Y; Irie K; Ohshima K; Hitotsumatsu T; Sato O; Arimura K
    Brain Tumor Pathol; 2009; 26(1):31-6. PubMed ID: 19408095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleomorphic xanthoastrocytoma with a gangliomatous component: an immunohistochemical and ultrastructural study.
    Kordek R; Biernat W; Sapieja W; Alwasiak J; Liberski PP
    Acta Neuropathol; 1995; 89(2):194-7. PubMed ID: 7732793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleomorphic xanthoastrocytoma with gangliogliomatous component.
    Vajtai I; Varga Z; Aguzzi A
    Pathol Res Pract; 1997; 193(9):617-21. PubMed ID: 9521020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleomorphic xanthoastrocytoma and desmoplastic infantile ganglioglioma--have these neoplasms a common origin?
    Kordek R; Biernat W; Alwasiak J; Liberski PP
    Folia Neuropathol; 1994; 32(4):237-9. PubMed ID: 7889337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotype of pleomorphic xanthoastrocytoma.
    Giannini C; Scheithauer BW; Lopes MB; Hirose T; Kros JM; VandenBerg SR
    Am J Surg Pathol; 2002 Apr; 26(4):479-85. PubMed ID: 11914626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical characterization of subependymal giant cell astrocytomas.
    Lopes MB; Altermatt HJ; Scheithauer BW; Shepherd CW; VandenBerg SR
    Acta Neuropathol; 1996; 91(4):368-75. PubMed ID: 8928613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleomorphic xanthoastrocytoma with anaplastic features presenting without GFAP immunoreactivity: implications for differential diagnosis.
    Gelpi E; Popovic M; Preusser M; Budka H; Hainfellner J
    Neuropathology; 2005 Sep; 25(3):241-6. PubMed ID: 16193842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas.
    Lee D; Cho YH; Kang SY; Yoon N; Sung CO; Suh YL
    J Surg Oncol; 2015 Mar; 111(3):359-64. PubMed ID: 25346165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron and microscopic study.
    Hirose T; Scheithauer BW; Lopes MB; Gerber HA; Altermatt HJ; Hukee MJ; VandenBerg SR; Charlesworth JC
    Acta Neuropathol; 1995; 90(4):387-99. PubMed ID: 8546029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pleomorphic xanthoastrocytoma and its differential diagnosis: a study of five cases.
    Kros JM; Vecht CJ; Stefanko SZ
    Hum Pathol; 1991 Nov; 22(11):1128-35. PubMed ID: 1743696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleomorphic xanthoastrocytoma - a clinico-pathological review.
    Sharma A; Nand Sharma D; Kumar Julka P; Kishor Rath G
    Neurol Neurochir Pol; 2011; 45(4):379-86. PubMed ID: 22101999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinico-pathological analysis of pilocytic astrocytomas and gangliogliomas.
    Fiks T; Jesionek-Kupnicka D; Zakrzewski K; Polis L; Liberski PP
    Pol J Pathol; 2001; 52(1-2):47-51. PubMed ID: 11505680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumors.
    Janss AJ; Yachnis AT; Silber JH; Trojanowski JQ; Lee VM; Sutton LN; Perilongo G; Rorke LB; Phillips PC
    Ann Neurol; 1996 Apr; 39(4):481-9. PubMed ID: 8619526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of neuronal markers, NFP and GFAP, in malignant astrocytoma.
    Hashemi F; Naderian M; Kadivar M; Nilipour Y; Gheytanchi E
    Asian Pac J Cancer Prev; 2014; 15(15):6315-9. PubMed ID: 25124617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of macrophage/histiocytic antigens in pleomorphic xanthoastrocytomas.
    Matyja E; Kroh H; Taraszewska A; NagaƄska E; Zabek M; Marchel A
    Folia Neuropathol; 2003; 41(2):89-95. PubMed ID: 12899201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique desmoplastic cerebral tumor in a patient with complex partial seizures.
    Jay V; Edwards V; Rutka J; Mosskin M; Hwang P; Resch L
    Pediatr Dev Pathol; 1998; 1(3):234-42. PubMed ID: 10463284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleomorphic xanthoastrocytoma: a developmental glioneuronal tumor with prominent glioproliferative changes.
    Im SH; Chung CK; Kim SK; Cho BK; Kim MK; Chi JG
    J Neurooncol; 2004 Jan; 66(1-2):17-27. PubMed ID: 15015766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological features of gliomas in children.
    Hirato J; Nakazato Y
    Noshuyo Byori; 1996 Apr; 13(1):37-47. PubMed ID: 8916125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.